Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Am J Obstet Gynecol. 2016 Feb 17;215(3):318.e1–318.e9. doi: 10.1016/j.ajog.2016.02.032

Table 1.

Socio-demographic characteristics of patients eligible to participate in the postpartum HPV vaccination program, and who had not received at least 1 HPV vaccine

Characteristics Enrolled in program, initiated vaccination (n=575) Declined to participate (n=184) P value
Age (years) n(%) .688
 14–20 130 (22.6) 39 (21.2)
 21–26 445 (77.4) 145 (78.8)
Race/ethnicity <.001
 Non-Hispanic white 141 (24.5) 62 (33.7)
 Non-Hispanic Black 120 (20.9) 43 (23.4)
 Hispanic 307 (53.4) 66 (35.9)
 Non-Hispanic others 7 (1.2) 13 (7.1)
Gravidity .459
 1 195 (34.0) 68 (37.0)
 2 or more 379 (66.0) 116 (63.0)
Age at 1st sexual intercourse .087
 ≤14 years old 91 (15.8) 29 (15.8)
 ≥15 years old 328 (57.0) 90 (48.9)
 Unknown 156 (27.1) 65 (35.3)
Number of lifetime sexual partners .160
 1 94 (16.4) 24 (13.0)
 2–5 194 (33.8) 54 (29.4)
 6 or more 101 (17.6) 30 (16.3)
 Unknown 186 (32.4) 76 (41.3)
STD history .173
 No 313 (58.8) 105 (64.8)
 Yes 219 (41.2) 57 (35.2)
History of tobacco use .478
 No 429 (76.5) 136 (79.1)
 Yes 132 (23.5) 36 (20.9)
History of marijuana use .699
 No 503 (90.8) 156 (91.8)
 Yes 51 (9.2) 14 (8.2)
History of alcohol use .046
 No 491 (88.2) 159 (93.5)
 Yes 66 (11.9) 11 (6.5)
Received influenza vaccine during this pregnancy <.001
 No 241 (42.7) 105 (60.3)
 Yes 324 (57.4) 69 (39.7)
Received any other vaccine postpartum .238
 No 376 (65.4) 129 (70.1)
 Yes 199 (34.6) 55 (29.9)
Obstetric complicationa
 No 376 (65.4) 133 (72.3) .083
 Yes 199 (34.6) 51 (27.7)
Cesarean delivery
 No 406 (70.6) 124 (67.4) .408
 Yes 169 (39.4) 60 (32.6)
Infant admitted to NICU
 No 505 (86.8) 160 (87.0) .755
 Yes 70 (12.2) 24 (13.0)
Intent to breastfeed
 No 92 (16.1) 23 (12.6) .243
 Yesb 478 (83.9) 160 (87.4)

Boldface indicates significant results.

a

Had any of the following complications recorded in the electronic medical records by a physician during this pregnancy: pregnancy induced hypertension, chronic hypertension, diabetes mellitus, chorioamnionitis, endometritis, preterm labor, preterm delivery, premature rupture of membranes (PROM), preterm PROM, postpartum hemorrhage, and oligohydramnios

b

Includes women who used both bottle and breast milk HPV, human papillomavirus; NICU, neonatal intensive care unit; STD, sexually transmitted disease.